相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association of ertapenem and antipseudomonal carbapenem usage and carbapenem resistance in Pseudomonas aeruginosa among 12 hospitals in Queensland, Australia
David A. J. McDougall et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Carbapenem stewardship – positive impact on hospital ecology
Ana Lucia Lei Munhoz Lima et al.
Brazilian Journal of Infectious Diseases (2012)
Changes in antibiotic usage and susceptibility in nosocomial Enterobacteriaceae and Pseudomonas isolates following the introduction of ertapenem to hospital formulary
C. J. Graber et al.
EPIDEMIOLOGY AND INFECTION (2012)
Carbapenem stewardship: does ertapenem affect Pseudomonas susceptibility to other carbapenems? A review of the evidence
David P. Nicolau et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Reduction in Fluoroquinolone Use following Introduction of Ertapenem into a Hospital Formulary Is Associated with Improvement in Susceptibility of Pseudomonas aeruginosa to Group 2 Carbapenems: a 10-Year Study
Paul P. Cook et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
The effects of group 1 versus group 2 carbapenems on imipenem-resistant Pseudomonas aeruginosa: an ecological study
Yehuda Carmeli et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2011)
Antimicrobial susceptibility of intra-abdominal Gram-negative bacilli from Europe: SMART Europe 2008
S. Hawser et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2011)
Hand Hygiene, and Not Ertapenem Use, Contributed to Reduction of Carbapenem-Resistant Pseudomonas aeruginosa Rates
Rodrigo Pires dos Santos et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2011)
Change in antipseudomonal carbapenem susceptibility in 25 hospitals across 9 years is not associated with the use of ertapenem
Kathryn J. Eagye et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Does Ertapenem Alter the Susceptibility of Pseudomonas aeruginosa to Carbapenems?
B. Beovic et al.
JOURNAL OF CHEMOTHERAPY (2011)
Antimicrobial Stewardship Lessons: Do Pseudomonas-Sparing Agents, Such as Ertapenem, Effectively Improve Bacterial Resistance?
Rodrigo Pires dos Santos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Introduction of Ertapenem into a Hospital Formulary: Effect on Antimicrobial Usage and Improved In Vitro Susceptibility of Pseudomonas aeruginosa
Ellie J. C. Goldstein et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
The Impact of Ertapenem Use on the Susceptibility of Pseudomonas aeruginosa to Imipenem: A Hospital Case Study
Ana Lucia L. Lima et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2009)
Ertapenem: No effect on aerobic gram-negative susceptibilities to imipenem
Debra A. Goff et al.
JOURNAL OF INFECTION (2008)
2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings
Jane D. Siegel et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2007)
The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection
Sheldon P. Stone et al.
LANCET INFECTIOUS DISEASES (2007)
Differential effects of levofloxacin and ciprofloxacin on the risk for isolation of quinolone-resistant Pseudomonas aeruginosa
KS Kaye et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Cloning and functional analysis of the gene encoding the 33- to 36-kilodalton outer membrane protein associated with carbapenem resistance in Acinetobacter baumannii
MDM Tomás et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infections
MJ DiNubile et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii:: patient prognosis and risk-factors for colonisation and infection
MD Tomas et al.
CLINICAL MICROBIOLOGY AND INFECTION (2005)
Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy
MJ DiNubile et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Selectivity of ertapenem for Pseudomonas aeruginosa mutants cross-resistant to other carbapenems
DM Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Epidemiological interpretation of antibiotic resistance studies - what are we missing?
MJ Schwaber et al.
NATURE REVIEWS MICROBIOLOGY (2004)
分享论文
